| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A brief history and challenges of clozapine utilization in the Arab world
|
Zolezzi, Monica
|
|
|
268 |
C |
p. 21-24
|
article
|
| 2 |
A brief history of clozapine in China with a look forward
|
Ruan, Can-Jun
|
|
|
268 |
C |
p. 25-28
|
article
|
| 3 |
A brief history of clozapine use in Taiwan
|
Lin, Shih-Ku
|
|
|
268 |
C |
p. 34-37
|
article
|
| 4 |
A case series of clozapine titrations affected by inflammatory processes
|
Leung, Jonathan G.
|
|
|
268 |
C |
p. 94-97
|
article
|
| 5 |
A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring
|
Jia, Fei
|
|
|
268 |
C |
p. 308-311
|
article
|
| 6 |
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
|
De las Cuevas, Carlos
|
|
|
268 |
C |
p. 165-174
|
article
|
| 7 |
A 12-month audit of clozapine associated myocarditis in a South Australian Local Health Network: The importance of screening and personalised titration
|
Carswell, Olivia
|
|
|
268 |
C |
p. 88-93
|
article
|
| 8 |
An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance
|
Sagud, Marina
|
|
|
268 |
C |
p. 53-59
|
article
|
| 9 |
An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance
|
Baptista, Trino
|
|
|
268 |
C |
p. 60-65
|
article
|
| 10 |
A scoping review of literature on clozapine from former USSR states published in Russian language
|
Kirilochev, Oleg
|
|
|
268 |
C |
p. 38-47
|
article
|
| 11 |
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital
|
Kang, Nuree
|
|
|
268 |
C |
p. 107-113
|
article
|
| 12 |
Association between initial pattern of clozapine titration, concentration-to-dose ratio, and incidence of fever in patients with schizophrenia spectrum disorders in a Korean tertiary hospital
|
Kang, Nuree
|
|
|
268 |
C |
p. 131-137
|
article
|
| 13 |
A systematic chart review of pharmacological interventions in patients with clozapine-induced hypersalivation
|
Mutlu, Emre
|
|
|
268 |
C |
p. 138-144
|
article
|
| 14 |
A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia
|
Cheuk, Natalie Kwok Wing
|
|
|
268 |
C |
p. 205-222
|
article
|
| 15 |
A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder
|
Faden, Justin
|
|
|
268 |
C |
p. 265-281
|
article
|
| 16 |
Brief commentary: Under-recognition of underuse of clozapine in treating psychotic symptoms in Parkinson's disease
|
Friedman, Joseph H.
|
|
|
268 |
C |
p. 282-284
|
article
|
| 17 |
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?
|
Schulte, Peter F.J.
|
|
|
268 |
C |
p. 285-288
|
article
|
| 18 |
Clozapine and its protective effect on all-cause, natural, and suicide mortality in patients with schizophrenia: A nationwide cohort study in Taiwan
|
Chen, Wen-Yin
|
|
|
268 |
C |
p. 150-160
|
article
|
| 19 |
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial
|
Kelly, Deanna L.
|
|
|
268 |
C |
p. 312-322
|
article
|
| 20 |
Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
|
de Filippis, Renato
|
|
|
268 |
C |
p. 118-130
|
article
|
| 21 |
Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond
|
Kane, John M.
|
|
|
268 |
C |
p. 9-13
|
article
|
| 22 |
Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?
|
Honigfeld, Gilbert
|
|
|
268 |
C |
p. 7-8
|
article
|
| 23 |
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards
|
Kuzo, Nazar
|
|
|
268 |
C |
p. 48-52
|
article
|
| 24 |
Clozapine safety monitoring and related research in psychiatry and neurology in South America: A scoping review
|
Baptista, Trino
|
|
|
268 |
C |
p. 29-33
|
article
|
| 25 |
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition
|
Schoretsanitis, Georgios
|
|
|
268 |
C |
p. 302-307
|
article
|
| 26 |
Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey
|
Niitsu, Tomihisa
|
|
|
268 |
C |
p. 82-87
|
article
|
| 27 |
Dotting the I's and crossing the T's: A South Australian perspective on variability in troponin thresholds for myocarditis risk in clozapine treatment
|
Clark, Scott R.
|
|
|
268 |
C |
p. 114-117
|
article
|
| 28 |
Editorial Board
|
|
|
|
268 |
C |
p. ii
|
article
|
| 29 |
Effect of clozapine on suicidality in patients with schizophrenia at a university hospital in Turkey
|
Gürcan, Gamze
|
|
|
268 |
C |
p. 161-164
|
article
|
| 30 |
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
|
Ruan, Can-Jun
|
|
|
268 |
C |
p. 293-301
|
article
|
| 31 |
Influence of time to clozapine prescription on the clinical outcome
|
Muñoz-Manchado, Leticia I.
|
|
|
268 |
C |
p. 189-192
|
article
|
| 32 |
Making sense of norclozapine levels: 3 clinical axioms
|
Meyer, Jonathan M.
|
|
|
268 |
C |
p. 289-292
|
article
|
| 33 |
Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore
|
Yang, Zixu
|
|
|
268 |
C |
p. 66-73
|
article
|
| 34 |
Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations
|
Verdoux, Hélène
|
|
|
268 |
C |
p. 243-251
|
article
|
| 35 |
Patient and caregivers perspective about clozapine: A systematic review
|
Grover, Sandeep
|
|
|
268 |
C |
p. 223-232
|
article
|
| 36 |
Prevalence and predictors of QTc prolongation in patients seen in a clozapine clinic in a real-world setting in Australia
|
Sankaranarayanan, Anoop
|
|
|
268 |
C |
p. 145-149
|
article
|
| 37 |
Promoting safer and wider worldwide use of clozapine
|
de Leon, Jose
|
|
|
268 |
C |
p. 1-6
|
article
|
| 38 |
Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia
|
Melzer-Ribeiro, D.L.
|
|
|
268 |
C |
p. 252-260
|
article
|
| 39 |
Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis
|
O'Donoghue, Brian
|
|
|
268 |
C |
p. 193-204
|
article
|
| 40 |
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
|
De las Cuevas, Carlos
|
|
|
268 |
C |
p. 175-188
|
article
|
| 41 |
Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?
|
Schulte, Peter F.J.
|
|
|
268 |
C |
p. 74-81
|
article
|
| 42 |
Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations
|
Verdoux, Hélène
|
|
|
268 |
C |
p. 233-242
|
article
|
| 43 |
Slower clozapine titration than the official Japanese protocol led to fewer inflammatory adverse effects: A retrospective chart review of seven hospitals
|
Kikuchi, Yuki
|
|
|
268 |
C |
p. 98-106
|
article
|
| 44 |
Sodium benzoate: A novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophrenia
|
Lin, Chieh-Hsin
|
|
|
268 |
C |
p. 261-264
|
article
|
| 45 |
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences
|
de Leon, Jose
|
|
|
268 |
C |
p. 14-20
|
article
|
Journal description